Literature DB >> 18063075

Utilization of total thyroidectomy for papillary thyroid cancer in the United States.

Karl Y Bilimoria1, David J Bentrem, John G Linn, Andrew Freel, Jen Jen Yeh, Andrew K Stewart, David P Winchester, Clifford Y Ko, Mark S Talamonti, Cord Sturgeon.   

Abstract

BACKGROUND: Despite guidelines that recommend total thyroidectomy for papillary thyroid cancer (PTC) greater than or equal to 1 cm, the extent of surgery remains controversial. We examined surgical practice patterns for PTC greater than or equal to 1 cm and identified factors that predict the use of total thyroidectomy.
METHODS: Of 90,382 patients in the National Cancer Center Data Base (NCDB) with PTC from 1985 to 2003, 57,243 patients had tumors greater than or equal to 1 cm and underwent total thyroidectomy or lobectomy. Trends in extent of surgery for PTC were examined over 2 decades. Logistic regression was used to identify factors that predict use of total thyroidectomy compared with lobectomy.
RESULTS: Use of total thyroidectomy increased from 70.8% in 1985 to 90.4% in 2003 (P < .0001). Patients were less likely to undergo total thyroidectomy if they were black, older than 45 years, had Medicare, had lower household incomes, or had less education (P < .0001). Moreover, patients treated at high-volume or academic centers were more likely to undergo total thyroidectomy than were patients examined at low-volume or community hospitals (P < .0001).
CONCLUSIONS: Use of total thyroidectomy for PTC greater than or equal to 1 cm increased over time. Differences in use of total thyroidectomy are related to patient, tumor, and hospital factors and likely reflect disparities in access to care.

Entities:  

Mesh:

Year:  2007        PMID: 18063075     DOI: 10.1016/j.surg.2007.09.002

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  14 in total

1.  Five-year follow-up of a randomized clinical trial of total thyroidectomy versus Dunhill operation versus bilateral subtotal thyroidectomy for multinodular nontoxic goiter.

Authors:  Marcin Barczyński; Aleksander Konturek; Alicja Hubalewska-Dydejczyk; Filip Gołkowski; Stanisław Cichoń; Wojciech Nowak
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

2.  Use of radioiodine after thyroid lobectomy in patients with differentiated thyroid cancer: does it change outcomes?

Authors:  Colleen M Kiernan; Alexander A Parikh; Lee L Parks; Carmen C Solórzano
Journal:  J Am Coll Surg       Date:  2014-12-17       Impact factor: 6.113

Review 3.  Thyroid carcinoma: the surgeon's perspective.

Authors:  Linwah Yip; Michael T Stang; Sally E Carty
Journal:  Radiol Clin North Am       Date:  2011-05       Impact factor: 2.303

4.  Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?

Authors:  Nathalie Chereau; Christophe Trésallet; Severine Noullet; Gaelle Godiris-Petit; Frédérique Tissier; Laurence Leenhardt; Fabrice Menegaux
Journal:  Langenbecks Arch Surg       Date:  2016-03-08       Impact factor: 3.445

5.  Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines.

Authors:  Carol M Lewis; Amy C Hessel; Dianna B Roberts; Yunxia Z Guo; F Christopher Holsinger; Lawrence E Ginsberg; Adel K El-Naggar; Randal S Weber
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-12

6.  The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence.

Authors:  Haejin In; Bridget A Neville; Stuart R Lipsitz; Katherine A Corso; Jane C Weeks; Caprice C Greenberg
Journal:  Ann Surg       Date:  2012-05       Impact factor: 12.969

7.  Thyroid cancer surgery in Germany: an analysis of the nationwide DRG statistics 2005-2006.

Authors:  Pietro Trocchi; Alexander Kluttig; Henning Dralle; Carsten Sekulla; Martin Biermann; Andreas Stang
Journal:  Langenbecks Arch Surg       Date:  2012-01-10       Impact factor: 3.445

8.  Age-based disparities in the use of total thyroidectomy for papillary thyroid carcinoma.

Authors:  I V Shevchyk; B A Cobian; S R Martinez
Journal:  Clin Transl Oncol       Date:  2017-04-24       Impact factor: 3.405

9.  Variation in the management of thyroid cancer.

Authors:  Megan R Haymart; Mousumi Banerjee; Di Yang; Andrew K Stewart; James C Sisson; Ronald J Koenig; Gerard M Doherty; Jennifer J Griggs
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

10.  National Trends in the Surgical Treatment of Non-advanced Medullary Thyroid Cancer (MTC): An Evaluation of Adherence with the 2009 American Thyroid Association Guidelines.

Authors:  Eun Hae Estelle Chang; Waseem Lutfi; Joseph Feinglass; Alexandra Eudokia Reiher; Tricia Moo-Young; Mihir Kiran Bhayani
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.